We followed an iterative, hands-on process, strategizing, sketching, testing, and refining, until we landed on a wireframe that balanced form and function
Therapy with GLP-1RA should therefore start with low doses that can be uptitrated ( GLP-1RA has been placed prominently in the international recommendations for the treatment of T2D as the first injectable agent before insulin due to the advantageous outcomes in cardiovascular safety studies that demonstrated a reduction of the combined cardiovascular endpoint three-component major adverse cardiovascular event (MACE-3
Physiological mechanisms for the increase in renal solute-free water clearance by a glucagon-like peptide-1 mimetic
In the LEAN trial, a small phase 2b trial, treatment with 1.8 mg/day liraglutide resulted in a histologic resolution of NASH and a decreased progression of fibrosis [27]
Ziegler, D., Papanas, N., Vinik, A
Glutathion comp provides you with 600 mg of reduced glutathione per daily serving supplemented by NAC, which enables your body to continuously produce its own